IIT Delhi Reasearcher Developing Covid-19 Vaccine To Reduce Blood Clotting Incidents
In the latest Covid-19 development, the IIT Delhi researchers are developing a vaccine to be used for Covid-19 infection, which will reduce blood clotting incidents. On February 16, the officials close to the development said, the "next-generation" vaccine is currently in the animal trials phase and will soon be conducted trials on humans. However, an official announced regarding the vaccine will be done after the DCGI and Union Ministry… read-more
Tags: Delhi Researchers, IIT Delhi, Covid-19, trials, Medical Supplies, Coronavirus Vaccines
Courtesy: The Free Press Journal
Corbevax, India’s First Heterologous Booster Vaccine For Covid, Approved By DCGI
The Covid-19 vaccine Corbevax, manufactured by BiologicalE in Hyderabad, is the first to be licensed as a heterologous booster in adults by Drugs Controller General of India. Individuals who had Covishield/Covaxin for their first two doses can get Corbevax as their third. Following the booster dosage of Corbevax, neutralizing antibodies against Omicron variation were identified in 91% of individuals who had received Covishield and in 75% who… read-more
Tags: Covid-19, Coronavirus Vaccines, Covaxin, COVISHIELD, Corbevax, Drugs Controller General of India
Courtesy: The Indian Express
No Communication Regarding Permission For 2-Dose Regimen Of ZyCoV-D: Zydus Life
Zydus Life has clarified that there has been no official communication regarding permission for the two-dose regimen of the needle-less ZyCoV-D vaccine. ZyCov-D, an indigenous DNA-plasmid-based vaccine against Sars-Cov-2, was given emergency use authorisation for restricted use last year by the Central Drugs Standard Control Organisation (CDSCO). The three-dose vaccine was found to be over 66% effective in the third phase clinical trial.
Tags: Covid-19, Coronavirus Vaccines, vaccines campaigns, Zydus Cadila, Needleless Vaccine
Courtesy: Live Mint
Kerala HC Seeks Centre's Response On Plea Re Post-Covid Vaccination Death
The Kerala HC has sought the Centre's response over a plea regarding a post-Covid-19 vaccination death. The post-mortem report of the deceased confirmed that death was due to intracranial bleeding. The Medical officer suspects that it was a case of thrombosis-with-thrombocytopenia-syndrome (TTS), a rare but well-known adverse event associated with the adenovirus vector-based Covishield vaccine. The plea argues that the victim had not been… read-more
Tags: Covishield vaccine, COVISHIELD, vaccine side effects, Coronavirus Vaccines, Vaccination Drive
Courtesy: Live Law
With Covid Cases Rising In National Capital, Experts Advises Not To Panic
The health ministry data shows 2,183 new infections in the country, which created mass panic over the emergence of XE, a sub-type of Omicron. However, experts have advised not to panic. Furthermore, more than 90% of the Delhi population is fully vaccinated. Notably, 97 out of every 100 Delhi residents had Covid antibodies through past natural infection or vaccination, reveals the sixth round of serological surveillance conducted in 2021.
Tags: Covid-19, Coronavirus Vaccines
Courtesy: Hindustan Times
PGI Chandigarh To Study Covid-19 Vaccine Mixing
The PGI Chandigarh has got the approval of the drug regulator of India to study the mixing of Covid-19 vaccines. The study would help conclude what happens when a person who is fully vaccinated with either Covishield or Covaxin would respond to getting the booster dose of the other vaccine. The purpose of the study is also to compare homologous vaccination to heterologous vaccination.
Tags: Covid-19, Coronavirus Vaccines, Covid-19 Vaccine, Covishield vaccine, Covaxin
Courtesy: The Economic Times
Citizens Above 60 Years To Take Booster Dose From March 16
Citizens above 60-year-age are now eligible to take COVID-19 booster dose, to enhance immunity, from March 16. Previously amid the third pandemic wave, the precautionary dose was allowed for frontline warriors and people with comorbidities. However, on March 14, Health Minister Mansukh Mandaviya announced the third vaccine shot for everyone, above 60-year. The decision came at a time, when the Union Government also approved COVID-19 vaccine… read-more
Tags: Covid-19, Coronavirus Vaccines, Covid Vaccine, Adults, vaccine dose
Courtesy: Hindustan Times
India Logs 5,476 New COVID-19 Cases, 158 Deaths In Last 24 Hours
India reported 5,476 new COVID-19 cases, on March 6. The Union Health Ministry has confirmed 9,754 recoveries and 158 deaths in the last 24 hours. While the active caseload stands at 59,442, taking the total caseload to 4,29,62,953. Furthermore, the current recovery rate in the country stands at 98.66%. However, IIT Kanpur has predicted fourth wave Covid-19 in June. Moreover, as of now, India has administered 178.83 crore vaccine doses.
Tags: India, Covid-19, Covid cases in India, Coronavirus Vaccines, covid positive
Courtesy: The Deccan Herald
India Logs 13,166 New COVID Cases, 302 Deaths In Last 24 Hour
India reports 13,166 new COVID-19 cases on February 25. The Union Health Ministry has confirmed 26,988 recoveries, and 302 deaths in the last 24 hours. While the active caseload in India is at 1,34,235, the current recovery rate in the country stands at 98.49%. However, on February 24, Delhi reported 556 Covid-19 cases and six deaths. Moreover, as of now, India has administered 176.86 crore vaccine doses to people.… read-more
Tags: India, Covid-19, Covid cases, Coronavirus Vaccines, Delhi
Courtesy: The Indian Express
11.88 Crore Unutilized Covid-19 Vaccine Doses Available In India, Says Health Ministry
As per the Ministry of Health and Family Welfare, more than 11.88 crore balance and unutilized COVID-19 vaccine doses are still available with States and Union Territories. "More than 171.48 crore vaccine doses have been provided to states and UTs, so far through Government of India and through direct state procurement category," stated the Ministry. Notably, The COVID-19 vaccination drive in India started on January 16, 2021.
Tags: India, Covid-19, Coronavirus Vaccines, unutilized, Ministry of Health and Family Welfare
Courtesy: ANI News